Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals ARWR
$ 19.68 0.9%

Годовой отчет за 2024 год
добавлен 26.11.2024

report update icon

Arrowhead Pharmaceuticals Мультипликаторы 2011-2024 | ARWR

Мультипликаторы по годам Arrowhead Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.2 -15.1 -17.2 -32.4 -94.1 55.3 -19.1 -7.8 -4.4 -3.2 -5.4 -5.4 -1.1 -11.9

P/S

714.5 12.9 12.4 33.0 90.4 22.3 64.6 8.6 2261.5 773.3 1804.9 574.7 164.4 126.1

EPS

-5 -1.9 -1.7 -1.4 -0.8 0.7 -0.7 -0.5 -1.3 -1.6 -1.2 -1.3 -1.9 -0.4

EV (Enterprise Value)

2.43 млрд 2.98 млрд 2.91 млрд 4.38 млрд 7.81 млрд 3.64 млрд 1.03 млрд 268 млн 306 млн 237 млн 200 млн 159 млн 28.5 млн 33.2 млн

EBITDA per Share

-4.88 -1.82 -1.61 -1.37 -0.88 0.699 -0.613 -0.437 -1.25 -1.63 -1.06 -0.897 -1.74 -1.34

EV/EBITDA

-30.8 -64.5 53.9 -19.8 -7.7 -3.6 -2.3 -3.7 -6.9 -1.1 -3.2

PEG

-0.74 0.21 0.26 0.4 0.96 0.26 0.5 -0.12 -0.27 0.11 -1.4 -0.17 0.0 -0.23

P/B

2.2 4.0 4.4 6.4 15.2 15.4 10.9 3.3 3.8 2.7 1.9 6.5 2.7 3.0

P/CF

-5.5 -20.1 -22.2 26.6 -83.1 23.3 -21.4 -8.5 -5.2 -4.4 -8.5 -8.6 -1.5 -6.9

ROE %

-323.27 -75.65 -42.09 -34.45 -18.31 27.85 -57.17 -42.51 -86.00 -83.87 -35.32 -121.02 -239.82 -24.90

ROA %

-52.60 -26.81 -25.44 -19.83 -16.18 19.43 -48.79 -33.05 -63.76 -69.51 -32.07 -83.43 -127.82 -19.69

ROCE %

-58.30 -31.82 -32.27 -26.44 -19.33 24.21 -56.36 -43.36 -77.72 -82.48 -29.89 -81.39 -188.30 -73.88

Current Ratio

- - - - - 2.7 6.4 3.6 3.5 6.5 13.1 3.3 1.2 3.8

DSO

- - 8.8 14.6 3.1 1.4 7.4 0.8 172.9 - - 105.2 6126.8 1982.4

DIO

- - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - -

Операционный цикл

- - 8.8 14.7 3.1 - - - - - - - - -

Финансовый цикл

- - 8.8 14.7 3.1 - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Arrowhead Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.38 -1.02 -1.24 - -0.96 0.46 -0.39 - -0.68 0.42 -0.6 - -0.29 -0.26 -0.2 -0.48 -0.13 -0.2 -0.03 0.12 0.21 -0.03 0.13 -0.12 -0.18 0.13 -0.18 -0.14 -0.07 -0.18 -0.17 -0.34 -0.32 -0.17 -0.32 -0.42 -0.27 -0.32 -0.41 -0.42 -0.22 -0.41 -0.28 -0.43 -0.23 -0.41 -0.33 -1.48 -0.71 -0.5 -0.25 -0.05 -0.25 0.4

EBITDA per Share

-1.38 -0.99 -1.24 - -0.93 0.47 -0.38 - -0.67 0.41 -0.59 - -0.29 -0.26 -0.22 -0.47 -0.15 -0.22 -0.04 0.13 0.2 -0.04 0.13 -0.09 -0.16 0.13 -0.17 -0.09 -0.06 -0.17 -0.19 -0.32 -0.31 -0.19 -0.31 -0.42 -0.26 -0.31 -0.45 -0.48 -0.24 -0.45 -0.18 -0.35 -0.23 0.07 -0.31 -1.35 -0.57 -0.41 -0.35 -0.18 -0.24 -0.5

ROE %

-187.35 -162.63 -126.26 -26.91 -42.10 -30.35 -31.00 -22.26 -29.11 -20.76 -37.77 -18.61 -26.43 -22.34 -19.34 -15.31 15.52 26.59 29.69 37.22 -31.39 -55.99 -42.34 -67.99 -35.56 -26.05 -46.04 -39.74 -49.81 -63.35 -77.71 -86.08 -85.29 -79.43 -75.14 -69.84 -60.85 -53.37 -49.44 -46.85 -83.18 -98.30 -123.40 -161.96 -270.09 -327.80 -335.23 -299.19 -1030.23 -964.64 -937.99 -888.96 -14.23 -19.43

ROA %

-66.59 -60.20 -41.62 -12.11 -12.11 7.13 7.98 2.77 -7.61 -11.68 -21.77 -12.00 -18.91 -17.45 -17.64 -13.94 9.06 17.47 20.68 24.66 -30.57 -50.36 -38.81 -57.30 -28.48 -19.80 -36.39 -29.81 -36.83 -46.68 -57.11 -66.02 -67.40 -64.29 -62.62 -59.25 -52.81 -47.12 -44.90 -42.45 -66.85 -76.78 -92.90 -111.73 -170.72 -202.79 -202.23 -182.72 -802.70 -765.81 -753.53 -715.66 -11.45 -15.64

ROCE %

-76.00 -67.53 -47.18 -13.64 -29.02 -30.24 -28.87 -20.64 -26.55 -17.08 -29.79 -16.33 -26.74 -23.94 -23.26 -19.13 -4.92 5.52 8.29 14.52 -0.48 -23.77 -10.88 -34.58 -35.32 -26.03 -53.08 -48.50 -57.70 -69.81 -68.18 -73.78 -74.22 -69.13 -71.22 -68.41 -59.86 -53.59 -51.69 -43.28 -56.59 -70.22 -78.66 -116.17 -216.49 -250.30 -265.99 -242.21 -166.66 -124.90 -115.96 -51.11 -13.08 -29.84

Current Ratio

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

- - - - 206.2 34.2 33.4 - 1.9 0.4 17.3 - 10.9 26.8 21.1 10.1 2.8 4.7 3.1 1.4 1.4 5.9 4.6 2.6 41.1 33.5 2.8 0.7 0.7 1.7 1.4 219.0 172.9 0.8 - - - 132.4 33.9 - - 20.0 156.4 156.4 156.4 198.4 35.8 8.3 17.9 2.7 - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - 112.0 - 108.7 99.0 170.0 90.9 271.4 186.9 120.1 44.7 128.6 128.3 124.2 30.8 95.9 45.9 39.2 21.9 66.3 44.0 47.2 16.1 48.4 44.6 44.6 48.4 148.6 -

Операционный цикл

- - - - 206.2 34.2 33.4 - 1.9 0.4 17.3 - 10.9 26.8 21.1 10.1 2.8 4.7 3.1 1.4 1.4 5.9 4.6 2.6 41.1 33.5 2.8 0.7 0.7 1.7 1.4 219.0 172.9 0.8 - - - 132.4 33.9 - - 20.0 156.4 156.4 156.4 198.4 35.8 8.3 17.9 2.7 - - - -

Финансовый цикл

- - - - 206.2 34.2 33.4 - 1.9 0.4 17.3 - 10.9 26.8 21.1 10.1 2.8 4.7 3.1 1.4 1.4 5.9 4.6 2.6 41.1 33.5 -109.2 0.7 -108.1 -97.3 -168.6 128.1 -98.5 -186.2 -120.1 -44.7 -128.6 4.1 -90.2 -30.8 -95.9 -25.9 117.2 134.6 90.2 154.4 -11.5 -7.8 -30.6 -41.9 -44.6 -48.4 -148.6 -

Все данные представлены в валюте USD